lung disease – APBN New Site

Harmless No More? Bacteria Prevalent in Respiratory Tract Identified as Key Factor in the Worsening of Lung Disease

December 2, 2022 . Posted in Bioboard, Vol 26 No 11 & 12

In a breakthrough by an international team of researchers, with researchers from Nanyang Technological University’s Lee Kong Chian School of Medicine in the lead, Neisseria subflava has been...

New Drug Target for Treating Idiopathic Pulmonary Fibrosis

February 5, 2022 . Posted in Eye on China, Vol 26 No 2

A closer look into discoidin domain receptors lead to the development of a novel inhibitor with better anti-fibrotic effect. Idiopathic pulmonary fibrosis (IPF) is a chronic fatal lung disease, where...

Research Collaboration to Develop Novel Therapies

May 27, 2020 . Posted in Inside Industry

Bayer and Curadev Pte Ltd. announced in late March 2020 the signing of a research collaboration and license agreement for Curadev’s Stimulator of Interferon Genes (STING) antagonist program....